SAREPTA THERAPEUTICS, INC. — Net Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/203e771e-2905-4b94-97fb-3e2bf6eebd1f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-713.4M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-084144 |
| FY 2024 | $235.2M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-029973 |
| FY 2023 | $-536.0M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-022036 |
| FY 2022 | $-703.5M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-005062 |
| FY 2021 | $-418.8M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002517 |
| FY 2020 | $-554.1M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-009835 |
| FY 2019 | $-715.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-006769 |
| FY 2018 | $-361.9M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005170 |
| FY 2017 | $-50.7M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-004107 |
| FY 2016 | $-267.3M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-002842 |
| FY 2015 | $-220.0M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013358 |
| FY 2014 | $-135.8M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-063997 |
| FY 2013 | $-571.5M | 1980-07-22 – 2014-03-31 | evidence 0001193125-14-188608 |
| FY 2012 | $-473.3M | 1980-07-22 – 2013-03-31 | evidence 0001193125-13-211458 |
| FY 2011 | $-327.7M | 1980-07-22 – 2012-03-31 | evidence 0001193125-12-223884 |
| FY 2010 | $-307.6M | 1980-07-22 – 2010-12-31 | evidence 0001193125-14-080447 |
| FY 2009 | $-275.5M | 1980-07-22 – 2009-12-31 | evidence 0001193125-13-109941 |
| FY 2008 | $-250.3M | 1980-07-22 – 2008-12-31 | evidence 0001193125-12-112142 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SAREPTA THERAPEUTICS, INC. — all facts · Revenue · Operating Income